Thyroid cancer: open trials in Taiwan

• NCT03093116

  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  Taiepi · Tainan · Taipei

  Registry updated 2026-05-27

• NCT07138261

  Taiwanese Anaplastic Thyroid Cancer Registry

  Research · National Health Research Institutes, Taiwan

  Kaohsiung Medical University, Kaohsiung City · National Taiwan University Hospital ,NTUH Hsin-Chu Branch, Sindian City · China Medical University Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Koo Foundation Sun Yat-Sen Cancer Center, Taipei · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei · Tri-Service General Hospital, Taipei · Chang Gung Memorial Hospital, Linkou, Taoyuan

  Registry updated 2025-08-22

• NCT03175224

  APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  Trial Treatment · Phase 2 · Apollomics Inc.

  National Taiwan University Hospital, Taipei

  Registry updated 2025-06-27

All Thyroid cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error